| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Infliximab |
| Brand | Inflectra® |
| Indication | For the treatment of Rheumatoid Arthritis, Adult Crohn’s disease, Paediatric Crohn’s disease, Ulcerative Colitis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis. |
| Assessment Process | |
| Rapid review commissioned | 10/09/2013 |
| Rapid review completed | 20/09/2013 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |